Skip to main content
Fig. 5 | Molecular Autism

Fig. 5

From: Impact of chronic intranasal oxytocin administration on face expression processing in autistic children: a randomized controlled trial using fMRI

Fig. 5

Treatment-specific effect on change-from-baseline average ROI activity during face processing. fMRI face processing responses (average change-from-baseline beta-values for the FACESvsFIX contrast) across all voxels within each of the ROIs are shown in bar graphs, for the oxytocin and placebo groups. Note that, even though not strictly significant, the oxytocin group generally displays a reduction in brain activity across the face processing network at T1 compared to T0. Error bars denote standard errors of the mean

Back to article page

Molecular Autism

ISSN: 2040-2392